ConductScience.org, home

Paper42100932

Disease phenotype affects treatment of late-onset inflammatory bowel disease: Analysis of a large UK cohort.

Foulser PFG and 11 others. Inflamm Bowel Dis, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Disease phenotype affects treatment of late-onset inflammatory bowel disease: Analysis of a large UK cohort. Papers, record 42100932. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42100932

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Disease phenotype affects treatment of late-onset inflammatory bowel disease: Analysis of a large UK cohort.
PubMed
Journal
Inflamm Bowel Dis
PubMed
Year
2026
PubMed
Publication types
Journal Article, Multicenter Study, Observational Study
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-10-02
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Foulser PFGPeter F Ghttps://orcid.org/0000-0003-2086-4714
2Martinez-Gili LLaurahttps://orcid.org/0000-0001-5271-9672
3Balarajah SSharmilihttps://orcid.org/0000-0003-0229-8528
4Sundramoorthi RRohan
5Alexander JLJames Lhttps://orcid.org/0000-0001-8542-327X
6Mullish BHBenjamin Hhttps://orcid.org/0000-0001-6300-3100
7Marchesi JRJulian Rhttps://orcid.org/0000-0002-7994-5239
8Parkes MMiles
9Orchard TRTimothy Rhttps://orcid.org/0000-0002-3358-663X
10Hicks LCLucy Chttps://orcid.org/0000-0002-3065-1635
11Williams HRTHorace R Thttps://orcid.org/0000-0001-5889-7584
12UK IBD BioResource InvestigatorsGroup

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Colitis, UlcerativeMajor topic
Crohn DiseaseMajor topic
Adolescent
Adult
Female
Humans
Male
Middle Aged
Young Adult
Adrenal Cortex Hormones
Age of Onset
Cohort Studies
Colectomy
Follow-Up Studies
Phenotype
Prognosis
Tumor Necrosis Factor-alpha
United Kingdom

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
National Institute of Health Research Imperial Biomedical Research Centre based at Imperial College London and Imperial College Healthcare NHS TrustPubMed
MR/Z504002/1Medical Research Council Clinician Scientist FellowshipPubMed
MR/Z504002/1National Institute of Health Research Imperial Biomedical Research CentrePubMed

Source PubMed

Download CSV of grants

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139096528Comparative Safety and Effectiveness of Ustekinumab and Anti-TNF in Elderly Crohn's Disease Patients.Inflamm Bowel Dis2025https://conductscience.org/library/papers/39096528PubMed
232097073Global ageing: successes, challenges and opportunities.Br J Hosp Med (Lond)2020https://conductscience.org/library/papers/32097073PubMed
325267328Oral corticosteroids and the risk of serious infections in patients with elderly-onset inflammatory bowel diseases.Am J Gastroenterol2014https://conductscience.org/library/papers/25267328PubMed
436098310Is it time to include older adults in inflammatory bowel disease trials? A call for action.Lancet Healthy Longev2022https://conductscience.org/library/papers/36098310PubMed
526928965Systematic Review and Meta-analysis: Phenotype and Clinical Outcomes of Older-onset Inflammatory Bowel Disease.J Crohns Colitis2016https://conductscience.org/library/papers/26928965PubMed
634481954Vedolizumab Is Associated With a Lower Risk of Serious Infections Than Anti-Tumor Necrosis Factor Agents in Older Adults.Clin Gastroenterol Hepatol2022https://conductscience.org/library/papers/34481954PubMed
732142940Progression of Elderly Onset Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis of Population-Based Cohort Studies.Clin Gastroenterol Hepatol2020https://conductscience.org/library/papers/32142940PubMed
833234880High Rates of Mortality in Geriatric Patients Admitted for Inflammatory Bowel Disease Management.J Clin Gastroenterol2022https://conductscience.org/library/papers/33234880PubMed
936681569Management of inflammatory bowel disease in the elderly: A review.Dig Liver Dis2023https://conductscience.org/library/papers/36681569PubMed
1029050646Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.Lancet2017https://conductscience.org/library/papers/29050646PubMed
1122605668Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease.Inflamm Bowel Dis2013https://conductscience.org/library/papers/22605668PubMed
1220951835Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease.Clin Gastroenterol Hepatol2011https://conductscience.org/library/papers/20951835PubMed
1330891808Early combined immunosuppression may be effective and safe in older patients with Crohn's disease: post hoc analysis of REACT.Aliment Pharmacol Ther2019https://conductscience.org/library/papers/30891808PubMed
1422890223Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry.Am J Gastroenterol2012https://conductscience.org/library/papers/22890223PubMed
1540089251Risk of Age-related and Disease-related Complications and Mortality in Elderly-onset Inflammatory Bowel Disease: A Population-based Study.Clin Gastroenterol Hepatol2025https://conductscience.org/library/papers/40089251PubMed
1639209204Epidemiology of Elderly Onset IBD: A Nationwide Population-Based Cohort Study.Clin Gastroenterol Hepatol2025https://conductscience.org/library/papers/39209204PubMed
1729102619Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.Gastroenterology2018https://conductscience.org/library/papers/29102619PubMed
1830616024Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis.Clin Gastroenterol Hepatol2019https://conductscience.org/library/papers/30616024PubMed
1937078376Patients with elderly onset inflammatory bowel disease have a decreased chance of initiation of all types of medications and increased risk of surgeries-A nationwide cohort study.Aliment Pharmacol Ther2023https://conductscience.org/library/papers/37078376PubMed
2026978725Medication Utilization and the Impact of Continued Corticosteroid Use on Patient-reported Outcomes in Older Patients with Inflammatory Bowel Disease.Inflamm Bowel Dis2016https://conductscience.org/library/papers/26978725PubMed

See all 35 referencesDownload CSV of references

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42100932

GET https://conductscience.org/api/papers/v1/42100932/references?page=2